TwinStrand
Seattle, United States · Founded 2016 · $71.5M raised
- Headquarters
- Seattle, Washington
- Employees
- 51–200
- Founded
- 2016
- Business Model
- B2B
- Total Funding
- $71.5M
- Last Round
- $50.0M Series BMay 2021
- Rounds
- 3
About
Biotech company developing Duplex Sequencing technology for ultra-accurate genomic analysis with 10,000x lower error rates.
Summary
TwinStrand is a Biotech company based in Seattle, United States, founded in 2016. It has raised $71.5M in total across 3 rounds, most recently a $50.0M Series B round in May 2021. Investors include Madrona Venture, Alexandria Venture Investments and Ridgeback Capital.
Tech & App Stack
8 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
May 2021
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...

Global fertility clinics platform
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Biopharmaceutical services company
